Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
3
×
clinical trials
fda
3
×
life sciences
national blog main
national top stories
abbvie
eli lilly
investing
medical device
startups
4d molecular therapeutics
acne
agenus
alkermes
allergan
ascension ventures
astrazeneca
auris health
avexis
bayer
biomx
bladder cancer
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
buprenorphine
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
cariprazine
celgene
centers for medicare and medicaid services
cormorant asset management
deals
What
treatment
3
×
digital
drug
fda
aiming
alkermes
antipsychotic
approved
benefits
bio
caveats
clinical
closed
commonly
companies
company
designed
disease
effect
epidemic
fatty
favor
financing
frenzied
gain
growing
incontinence
known
led
liver
medicine
merck
million
nash
news
offer
panel
prescribed
proceeds
psyche
Language
unset
Current search:
treatment
×
fda
×
" boston top stories "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
